INTRODUCTION
============

Organization of Golgi components into a single complex localized in the perinuclear cell area in the proximity of the centrosome is a characteristic feature of mammalian cells ([@B68]; [@B28]; [@B66]). How such an organization is developed and maintained, however, is poorly understood. Several factors are known to be integral to Golgi complex organization. The matrix proteins GRASP65, GRASP55, GM130, and GMAP210 are believed to tether Golgi cisternae to each other and keep them together ([@B52]; [@B62]). In addition, the cytoskeleton plays an important role in the maintenance of Golgi architecture and its proper positioning in the cell.

The role of microtubules has been studied extensively for decades (for review see [@B68]; [@B66]). Microtubule depolymerization by means of nocodazole and other related drugs leads to rapid deterioration of the Golgi structure and the appearance of newly formed Golgi ministacks at endoplasmic reticulum (ER) exit sites scattered throughout the cell ([@B18]; [@B65]; [@B68]). Recovery of the Golgi following drug removal depends on the directional, retrograde movement of these ministacks along microtubules, their accumulation in the pericentrosomal area, and their subsequent fusion into ribbons ([@B68]; [@B45]). Both radial microtubule arrays nucleated by the centrosome and microtubules nucleated or stabilized by the Golgi elements themselves ([@B15]; [@B24]; [@B35]; [@B55]) participate in the recovery of the Golgi ribbon structure ([@B35]; [@B45]). In some cell types treated with the microtubule-stabilizing drug Taxol ([@B60]), remodeling of the Golgi ribbons also occurs ([@B77]; [@B36]); however, this process is slower and leads to a lower degree of fragmentation than Golgi dispersion induced by microtubule depolymerization.

Movement of Golgi elements along microtubules depends on microtubule-based molecular motors. Among these are cytoplasmic dynein ([@B19]; [@B10]; [@B68]; [@B1]) and several kinesins ([@B23]; [@B79]; [@B64]; [@B31]). The dynactin molecular complex, linking the microtubule motors with various cargos, including Golgi membrane elements ([@B61]), was shown to be required for the maintenance of the Golgi architecture ([@B11]; [@B10]).

In addition to microtubules, the actin cytoskeleton seems to affect Golgi architecture and positioning. Structural information concerning the association of actin filaments with Golgi membranes is limited, although immuno--electron microscopy revealed β- and γ-actin at the Golgi-associated COPI-coated buds ([@B70]), and short filaments decorated with the tropomyosin isoform Tm5NM-2 were detected at the budding zones on the ends of Golgi cisternae ([@B51]). Other studies suggest that the Golgi membrane might be surrounded by a spectrin--actin network, similar to that underlying the erythrocyte membrane ([@B5]; [@B34]; [@B20]; [@B37]).

A number of agents that affect the polymerization status of actin filaments were shown to perturb Golgi morphology and integrity. In particular, in several types of cultured cells, actin depolymerization by means of C2 botulinum toxin, cytochalasin D, or latrunculin B led to compaction of the Golgi and an apparent reduction in its projected area ([@B69]; [@B39]). Electron microscopy studies revealed the swelling of Golgi cisternae in such cells ([@B39]). This effect seems to be cell-type specific, since in cells of neural origin, latrunculin and cytochalasin produced dispersion of the Golgi complex rather than its compaction ([@B12]; [@B56]).

Both myosin-driven actin movement and actin polymerization can affect Golgi organization and dynamics. Myosin VI localizes to the Golgi and is essential to normal Golgi morphology ([@B74]; [@B58]). Myosin 18 interacts with the Golgi membrane phospholipid phosphatidylinositol-4-phosphate via the GOLPH3 linker and controls the flattened shape of Golgi cisternae ([@B22]). Myosin II is associated with Golgi membranes via interaction with Rab6, a Golgi-specific G-protein, and is involved in Golgi membrane fission ([@B47]). Myosin 1b was recently shown to promote the formation of post-Golgi carriers ([@B1a]).

Experimental manipulations with several proteins that regulate the dynamics of actin filaments also produced structural and functional alterations in the Golgi apparatus. Both activation and knockdown of the actin-depolymerizing factor ADF/cofilin produce specific changes in Golgi-mediated secretion and trafficking events ([@B59]; [@B72]). A major regulator of cofilin, LIM kinase 1, was shown to be localized at the Golgi ([@B26]) and affect its dynamics via cofilin phosphorylation ([@B56]; [@B59]). Actin filament nucleation by means of the Arp2/3 complex may also control Golgi organization and function. Indeed, the WHAMM protein (WASP homologue associated with actin, membranes, and microtubules), a novel actin nucleation-promoting factor that activates the Arp2/3 complex, was shown to associate with Golgi membranes and regulate Golgi architecture and ER-to-Golgi transport ([@B13]).

Formin-family proteins stimulate both nucleation and elongation of actin filaments ([@B17]; [@B29]; [@B16]). In particular, mammalian Diaphanous-related formin 1 (mDia1), a direct target of small GTPase Rho ([@B76]), is a potent activator of actin polymerization in vitro ([@B41]). The Diaphanous-related formins, and specifically mDia1, were shown to be involved in a variety of in vivo functions (for review see [@B49]; [@B16]), which include regulation of both cell polarity and intracellular trafficking of vesicles and organelles ([@B43]; [@B25]; [@B46]; [@B80]; [@B73]; [@B63]).

In the present study, we address the effects of mDia1 and its activator, RhoA, on the architecture and dynamics of the Golgi apparatus. We found that activation of the Rho--mDia1 pathway indeed induced marked reorganization of the Golgi, which depends on the actin cytoskeleton and can be greatly enhanced by the microtubule-stabilizing drug Taxol. We present evidence that Rho--mDia1 is involved in regulating the fusion of the Golgi membranes and formation of Rab6-positive Golgi-derived transport carriers and plays a critical role in Golgi complex integrity.

RESULTS
=======

Activation of RhoA induces dispersion of the Golgi complex
----------------------------------------------------------

In HeLa JW cells ([@B50]), expression of a constitutively active mutant of RhoA (RhoA-V14) produces a marked alteration in Golgi complex organization.

Labeling of Golgi with the *trans*-Golgi marker GalT--yellow fluorescent protein (YFP) (YFP fused to the N-terminus of β-galactosyltransferase) revealed disruption of the Golgi ribbon structure into smaller elements dispersed from the narrow perinuclear area over the entire central part of the cell ([Figure 1A](#F1){ref-type="fig"}, top). A similar effect was observed using markers of medial Golgi (mannosidase II--green fluorescent protein \[GFP\]) or *cis*-Golgi (endogenous p115, Grasp65) (see [Figures 3](#F3){ref-type="fig"} and [6](#F6){ref-type="fig"} later and Supplemental Figures S1--S3). The active form of RhoB also triggered Golgi dispersion, whereas another small GTPase, Rac, did not produce any effect on Golgi morphology (unpublished data).

![Golgi dispersion induced by active RhoA is an mDia1-dependent process. (A, B) Control HeLa JW cells (con) and mDia1 knockdown cells (shDia1) were either (A) transfected with constitutively active Rho (RhoA-V14) and fixed 24 h later or (B) treated with RhoA activator LPA (12 μM) in serum-free medium and filmed for 2 h (see Supplemental Movie S2). (A) Golgi was visualized by transfection with *trans*-Golgi marker GalT-YFP (green; see also the enlarged insets) and actin by staining with phalloidin (red). RhoA-V14--transfected cells in A are marked by white asterisks. In B Golgi was visualized by ManII-GFP. Scale bars, (A) 10 μm, (B) 10 μm. (C, D) Degree of Golgi dispersion was quantified using a compactness (circularity) index calculated on the basis of morphometric measurements ([@B3]; see also *Materials and Methods*). Bars represent compactness values ± SEM. The p values were calculated according to Student\'s *t test.* (C) Compactness values for control (con) and mDia1-knockdown (shDia1) cells treated, or not treated, with LPA were measured on fixed specimens stained with p115 *cis*-Golgi marker. (D) Effect of RhoA-V14 on Golgi compactness in control (con) and Dia1-knockdown (shDia1) cells. (E) Western blot illustrating the depletion of mDia1 in HeLa JW cells expressing mDia1-targeted shRNA.](2900fig1){#F1}

![An active form of mDia1 (mDia1ΔN3) induces Golgi dispersion in an actin polymerization--dependent manner. (A) Cells were transfected with Golgi marker ManII-GFP, shown in red (con), or cotransfected with ManII-GFP and constitutively active mDia1 (mDia1ΔN3). Latrunculin B at 2 μM concentration was added 24 h after transfection; cells were fixed 2 h later. F-Actin was visualized by phalloidin staining (green). Scale bar, 10 μm. (B) Dispersion of Golgi induced by mDia1ΔN3 is gradually reduced in cells treated with ascending concentrations of latrunculin B. Complete return of the compactness value to control levels was observed in 10 μM latrunculin B--treated, mDia1ΔN3-transfected cells. Error bars in B represent SEM values.](2900fig2){#F2}

![Active Rho prevents fusion of Golgi elements into ribbon structures. (A) Cells expressing the Golgi marker ManII-GFP, alone or in combination with plasmids encoding shRNA against mDia1 or constitutively active Rho, were treated with nocodazole (2.5 μM) for 3 h until the Golgi elements were completely dispersed. Nocodazole was then washed out, and the process of Golgi recovery was filmed in a time-lapse manner. Frames from the three time-lapse movies taken for cells of each type at indicated time points are shown in montage A (see Supplemental Movies S5 and S6). Scale bar, 10 μm; time, minutes. Note that even though Golgi elements move centripetally in all cases, efficient fusion of dispersed elements into ribbon structures occurs in control and mDia1 knockdown cells but not in cells expressing active RhoA. (B) Quantification of average size and number of Golgi elements at different time points after nocodazole removal. (C) Quantification of the effect of latrunculin and constitutively active mDia1 (mDia1ΔN3) on the dynamics of Golgi recovery after nocodazole treatment. The corresponding movie frames are shown in Supplemental Figure S3. The data are normalized to their initial value at the zero time point. Particle size (in μm^2^) at the zero time point (average ± SD): control (1.3 ± 0.32), RhoV14 (1.3 ± 0.4), siDia1 (1.7 ± 0.4), mDia1ΔN3 (0.54 ± 0.14), and LatB (0.54 ± 0.15). Particle number at the zero time point (average ± SD): control (86 ± 15.8), RhoV14 (66 ± 12.27), siDia1 (64.4 ± 35.9), mDia1ΔN3 (106 ± 61.5), and LatB (57.6 ± 25). For each cell type, 7--10 time-lapse movies were taken for this analysis. Error bars show SD.](2900fig3){#F3}

![Dynamics of Golgi fragmentation and dispersion induced by Taxol in active mDia1-expressing cells. Sequences from time-lapse movies illustrating the effect of Taxol (24 μM) on microtubules (green) and Golgi (red) in a control cell (top) and an mDia1ΔN3-expressing cell (bottom). Microtubules and Golgi were visualized by transfection of cherry-α-tubulin and ManII-GFP, respectively. Time after addition of Taxol is shown in minutes. Note that Taxol treatment leads to the formation of prominent microtubule bundles in both control and mDia1-expressing cells. In control cells, Golgi membranes remain associated with the ends of these bundles and do not undergo fragmentation. In mDia1ΔN3-transfected cells, a large Golgi fragment can move either together with moving bundles (arrows) or along such bundles (arrowheads). The process of fragmentation continues during the course of such movement (see Supplemental Movie S7). Scale bar, 5 μm.](2900fig4){#F4}

![Golgi dispersion induced by active mDia1 is enhanced by Taxol in an actin- and myosin II--dependent manner. HeLa JW cells transfected with GalT-YFP Golgi marker (green) alone (con) or together with active mDia1 (mDia1ΔN3) were either left untreated or incubated for 3 h with the microtubule-stabilizing drug Taxol (24 μM) alone (Taxol), with Taxol in combination with blebbistatin (50 μM) (Taxol + Bleb), or with Taxol and latrunculin B (2 μM) (Taxol + LatB). Microtubules (red) and F-actin (black and white photos) were visualized in the same cells by staining with antibody against tubulin and with phalloidin, respectively. Note that Taxol treatment does not induce significant Golgi dispersion in and of itself but strongly stimulates it in cells expressing active mDia1. Both inhibition of actin polymerization by latrunculin B and inhibition of myosin II activity by blebbistatin abolished this effect. Scale bar, 10 μm.](2900fig5){#F5}

![Dispersed Golgi elements preserve a ministack structure. (A) The Golgi compartments were labeled by cell transfection with the *trans*-Golgi marker GalT-YFP (green) and immunofluorescence staining with antibody to the *cis*-Golgi marker p115 (red). Nonfragmented Golgi in control or Taxol-treated cells display typical *cis* and *trans* cisternae, forming the ribbon structure. Fragmented Golgi elements in RhoA-V14-- or mDia1ΔN3-expressing cells, and even the smallest fragments in RhoA-V14--expressing cells treated with taxol, still preserve joint *cis* and *trans* markers. Scale bar, 10 μm. (B) Transmission electron microscopy of control cells and cells expressing mDia1ΔN3. Arrows indicate the Golgi stacks; n, nucleus. Scale bar, 500 nm. Golgi elements in mDia1ΔN3 cells preserved a stacked structure.](2900fig6){#F6}

Lysophosphatidic acid (LPA) treatment is known to rapidly activate Rho ([@B53]); its activation made it possible to track the dynamics of Golgi reorganization. Experiments with LPA stimulation were performed in serum-free medium ([@B53]); serum starvation by itself did not decrease the Golgi compactness ([Figure 1, C and D](#F1){ref-type="fig"}). Time-lapse filming of control cells showed that Golgi elements were mobile, but overall ribbon organization remained generally unchanged throughout the observation period (Supplemental Movie S1). Time-lapse filming of LPA-treated cells revealed the dispersion and centrifugal movement of the Golgi elements. In less than 2 h, the ribbons underwent fragmentation into smaller elements that dispersed radially outward from the cell center (Supplemental Movie S2 and [Figure 1B](#F1){ref-type="fig"}, top).

The extent of fragmentation and dispersion of the Golgi was similar to that produced by expression of constitutively active Rho ([Figure 1A](#F1){ref-type="fig"}, top). The degree of Golgi dispersion was quantified using the index of "compactness" or "circularity" ([@B3]); the value of this index dropped twofold both in cells treated with LPA and in cells expressing constitutively active Rho ([Figure 1, C and D](#F1){ref-type="fig"}).

Effects of active RhoA on Golgi organization requires mDia1
-----------------------------------------------------------

Because mDia1 is a well-known primary target of Rho, we investigated whether Rho-induced Golgi dispersion is mediated by this Rho effector. To this end, we examined whether constitutively active RhoA or LPA treatment would affect Golgi organization in mDia1 knockdown cells ([Figure 1](#F1){ref-type="fig"}). A HeLa JW cell line stably expressing a vector encoding shRNA for mDia1 ([@B14]) was used in these experiments. The level of mDia1 expression in these cells decreased more than 90%, as revealed by Western blotting ([Figure 1E](#F1){ref-type="fig"}). We found that neither transfection with active RhoA nor treatment with LPA led to significant dispersion of the Golgi in mDia1-depleted cells ([Figure 1, A and B](#F1){ref-type="fig"}, bottom). Our measurements revealed that Golgi compactness in mDia1 knockdown cells treated with LPA or transfected with constitutively active Rho did not differ from that in control cells ([Figure 1, C and D](#F1){ref-type="fig"}). Of note, in mDia1 knockdown cells with nonstimulated RhoA, a slight increase in compactness above control levels was detected. In line with these results, we found that RhoA activation led to the enrichment of mDia1-GFP in the cell area occupied by the Golgi complex (Supplemental Figure S1).

Active mDia1 induces Golgi dispersion in an actin polymerization-- and myosin II--dependent manner
--------------------------------------------------------------------------------------------------

Golgi dispersion in LPA-treated cells is accompanied by the transient appearance of F-actin patches in the proximity of Golgi elements, as revealed by live imaging of mCherry-LifeAct--labeled cells (Supplemental Movie S3). To determine whether the effect of active mDia1 on Golgi integrity depends on actin polymerization, we treated cells with the actin polymerization inhibitor latrunculin B ([@B48]) and observed that such treatment reverses the effect of mDia1 on Golgi dispersion ([Figure 2](#F2){ref-type="fig"}).

Transfection of cells with a constitutively active truncated construct of mDia1 known as mDia1ΔN3 ([@B75]) produced the apparent dispersion of Golgi to an even more pronounced degree than that induced by Rho activation ([Figure 2A](#F2){ref-type="fig"}, left; also see [Figure 6A](#F6){ref-type="fig"} later). Latrunculin increased Golgi compactness, in agreement with previous results ([@B39]) ([Figure 2A](#F2){ref-type="fig"}, top right panel, and [Figure 2B](#F2){ref-type="fig"}), whereas mDia1ΔN3 significantly decreased this morphometric parameter ([Figure 2B](#F2){ref-type="fig"}). In cells expressing mDia1ΔN3, a gradual increase in LatB concentration reduced the mDia1 effect, returning Golgi compactness to control levels at 10 μM ([Figure 2B](#F2){ref-type="fig"}). Taken together, these findings show that Rho-induced Golgi fragmentation is mediated by activation of mDia1; moreover, this effect depends on actin polymerization.

Similar to mDia1, myosin II activity is controlled by Rho ([@B71]). Cell treatment with blebbistatin, an inhibitor of myosin II activity, produced some fragmentation of the Golgi complex (Supplemental Figure S2A). Measurements of Golgi compactness revealed, however, that fragmentation induced by constitutively active mDia1 was significantly more pronounced (Supplemental Figure S2B). Moreover, blebbistatin prevented the decrease of Golgi compactness induced by active mDia1 expression (Supplemental Figure S2, A and B). Thus, mDia1 functions in concert with myosin II in the process of Rho-dependent Golgi fragmentation and dispersion.

Rho and mDia1 activation interfere with the fusion of Golgi elements recovering from nocodazole treatment
---------------------------------------------------------------------------------------------------------

Depolymerization of microtubules by nocodazole treatment led to the pronounced disruption of the Golgi complex and the appearance of numerous dispersed Golgi elements ([@B67], [@B68]). This process requires de novo formation of numerous Golgi ministacks at the cell periphery, presumably at ER exit sites ([@B18]; [@B65]) (Supplemental Movie S4). We found that microtubule depolymerization leads to pronounced Golgi dispersion not only in control cells, but also in mDia1-depleted cells and in cells with active mDia1. This finding enabled us to study how manipulations with Rho and mDia1 affect the recovery of dispersed Golgi following nocodazole removal.

Live imaging of Golgi recovery revealed that this is a two-stage process ([Figure 3A](#F3){ref-type="fig"} and Supplemental Movies S5 and S6). The first stage comprises the rapid centripetal movement of Golgi fragments, leading to their concentration in the perinuclear area. In the second stage, the small fragments coalesce, or "fuse," forming large, ribbon-like structures. We characterized the extent of Golgi complex recovery by measuring the average size (projected area) of individual Golgi fragments and the average number of such fragments per cell ([Figure 3B](#F3){ref-type="fig"}).

The rate of fusion between Golgi elements during the second stage of recovery differed, depending on mDia1 and RhoA status. The fusion rate was maximal in mDia1 knockdown cells and eventually led to the efficient and rapid recovery of the Golgi in such cells ([Figure 3A](#F3){ref-type="fig"} and Supplemental Movie S5). Control cells displayed a somewhat slower fusion rate ([Figure 3A](#F3){ref-type="fig"} and Supplemental Movie S5), whereas the fusion of Golgi elements in cells expressing active Rho or active mDia1 was inefficient ([Figure 3A](#F3){ref-type="fig"}, Supplemental Figure S3, and Supplemental Movie S6). These conclusions were supported by a rapid decrease in number and increase in size of Golgi elements in both mDia1-knockdown cells and in control cells ([Figure 3B](#F3){ref-type="fig"}). At the same time, the number and size of Golgi fragments changed much more slowly in cells expressing active RhoA or active mDia1 ([Figure 3, B and C](#F3){ref-type="fig"}), even though these particles were concentrated in the central part of the cell ([Figure 3A](#F3){ref-type="fig"}, Supplemental Figure S3, and Supplemental Movie S6). These results suggest the involvement of Rho--mDia1 signaling during the fusion of Golgi elements into ribbon-like structures. Cells treated with latrunculin demonstrated slightly more efficient fusion of Golgi elements, in a manner similar to mDia1 knockdown ([Figure 3C](#F3){ref-type="fig"} and Supplemental Figure S3).

Effects of Taxol on Rho-mDia1--mediated Golgi dispersion
--------------------------------------------------------

We next studied the effect of the microtubule-stabilizing drug Taxol ([@B60]) on Golgi reorganization induced by activation of the RhoA--mDia1 pathway. Surprisingly, Taxol treatment strongly enhanced the Golgi dispersion induced by either mDia1ΔN3 or RhoA-V14 ([Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}, Supplemental Movie S7, and unpublished data). Incubation of cells with Taxol for 3 h led to formation of prominent microtubule bundles ([Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}), in agreement with previous studies ([@B60]). Live imaging of cells with labeled *trans*-Golgi and microtubules revealed the kinetics of microtubule-dependent Golgi dispersion ([Figure 4](#F4){ref-type="fig"} and Supplemental Movie S7). In Taxol-treated cells that did not contain active mDia1, Golgi elements were concentrated near the ends of the microtubule bundles, usually in the cell center, and displayed essentially normal compact morphology ([Figure 4](#F4){ref-type="fig"} and Supplemental Movie S7). In Taxol-treated cells expressing the active form of mDia1, newly formed microtubule bundles often moved from the center of the cell to the periphery ([Figure 4](#F4){ref-type="fig"} and Supplemental Movie S7) along with the Golgi fragments associated with them. This process was accompanied by further fragmentation of Golgi elements ([Figure 4](#F4){ref-type="fig"} and Supplemental Movie S7). In some cases, Golgi elements moved along microtubule bundles ([Figure 4](#F4){ref-type="fig"} and Supplemental Movie S7). As a result, cells expressing active mDia1 that were incubated with Taxol for 3 h displayed strong fragmentation of the Golgi complex and dispersion of Golgi elements throughout the entire cell area ([Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}).

Enhanced Golgi dispersion induced by Taxol in cells expressing active mDia1 can be prevented by simultaneous treatment of cells with latrunculin B or with the myosin II inhibitor blebbistatin ([Figure 5](#F5){ref-type="fig"}). Thus, Taxol treatment significantly enhanced Golgi fragmentation and dispersion induced by active mDia1, whereas inhibition of actin polymerization or myosin II--driven contractility suppressed both Golgi fragmentation and dispersion.

Golgi fragmentation induced by active Rho and mDia1 leads to formation of Golgi ministacks
------------------------------------------------------------------------------------------

To characterize the elements into which the Golgi complex is dispersed under conditions of Rho or mDia1 activation, we visualized the *cis*- and *trans*-Golgi compartments using corresponding markers (the *trans*-Golgi marker GalT-YFP and the *cis*-Golgi marker p115). As described in previous studies, *cis*- and *trans*-Golgi compartments are spatially separated but adjacent to each other ([@B57]; [@B28]). Analysis of Golgi organization upon activation of Rho or mDia1 under various experimental conditions ([Figure 6](#F6){ref-type="fig"}) revealed that even the smallest fragments of Golgi contained both *cis* and *trans* compartments. In particular, the fragments resulting from maximal Rho-mDia1--mediated Golgi fragmentation (in cells expressing active RhoA and treated with Taxol) still consisted of spatially separated regions positive for *cis* and *trans* markers ([Figure 6A](#F6){ref-type="fig"}). The immunofluorescence observations were confirmed by transmission electron microscopy of control cells and cells expressing active mDia1. In both cases, Golgi stack structures were seen in the cells, even though in cells expressing mDia1ΔN3 they were smaller and slightly swollen ([Figure 6B](#F6){ref-type="fig"}). Thus, Golgi dispersion induced by Rho--mDia1 activation led to the production of ministacks rather than the separation of the Golgi complex into individual cisternae.

The Rho--mDia1 pathway is involved in the formation of Rab6-positive, Golgi-derived vesicles
--------------------------------------------------------------------------------------------

The small GTPases Rab6A and Rab6A′ localize to the *trans*-Golgi network and mark Golgi-derived exocytotic carriers, as well as vesicles involved in Golgi-to-ER retrograde transport ([@B44]; [@B27]; [@B78]; [@B21]; [@B30]). To gain deeper insights into the functional role of the RhoA--mDia1 pathway in Golgi dynamics, we examined the effects of RhoA activation and mDia1 knockdown on the generation of Rab6A-positive transport carriers ([Figure 7](#F7){ref-type="fig"} and Supplemental Movies S8 and S9). We found that Rho activation significantly increased the abundance of such vesicles in comparison to control cells ([Figure 7, A](#F7){ref-type="fig"} and B, and Supplemental Movie 8), whereas mDia1 knockdown completely abolished this increase ([Figure 7, A and B](#F7){ref-type="fig"}, and Supplemental Movie S9). Of note, the Rab6A-positive tubular extensions radiating from the Golgi, as well as elongated tubular cytoplasmic vesicles, were more prominent in mDia1 knockdown cells, suggesting a fission defect (Supplemental Movie S9). Active RhoA did not appear to decrease the fraction of these Rab6A-positive tubular elements in mDia1-depleted cells (Supplemental Movie S9).

![Production of Rab6-positive transport carriers is enhanced by active RhoA and inhibited by mDia1 knockdown. (A) Rab6A-GFP was transiently expressed in control HeLa JW cells (con), in cells expressing active RhoA (RhoA-V14), in mDia1 knockdown cells (shDia1), and in mDia1 knockdown cells expressing active RhoA. Rab6A-GFP localizes to Golgi-derived vesicular and tubular carriers. Note the numerous vesicles in control cells expressing RhoA-V14 and the elongated (tubular) morphology of Rab6 membranes in mDia1 knockdown cells with or without active RhoA (insets). Scale bars, 10 and 4 μm (insets). (B) The density of Rab6-positive carriers increases in control but not in mDia1 knockdown cells expressing active RhoA. Error bars show SD.](2900fig7){#F7}

To determine the mode of action of mDia1 in formation of Rab6-positive vesicles, we used spinning disk confocal microscopy to study the colocalization of GFP-mDia1 and Cherry-Rab6A′ in cells expressing active Rho (RhoA V14). We found that both vesicular and tubular Rab6A′-positive structures often colocalize with small mDia1-positive patches ([Figure 8](#F8){ref-type="fig"}). This colocalization event was very transient (no more than 30 s); however, such events could be seen in almost every frame ([Figure 8](#F8){ref-type="fig"}). We found no colocalization of mDia1 and Rab6A′ in cells that did not express RhoA-V14 (unpublished data). Taken together, these results suggest that RhoA promotes the formation of Rab6-positive vesicles via activation of mDia1, which then transiently colocalizes with these structures.

![Colocalization of mDia1 and Rab6A′ in cells expressing constitutively active RhoA. Cells were triple transfected with GFP-mDia1 (green), Cherry-Rab6A′ (red), and RhoA-V14-VSV (not shown). The colocalization regions in the merged images are colored yellow. The images of the same cell at two different time points are shown in top and bottom rows, respectively. Some sites of colocalization are indicated by arrowheads and numbered. Insets on the right show magnified images corresponding to these colocalization events. Scale bars, 10 and 1.5 μm (insets).](2900fig8){#F8}

Because Rab6-positive carriers are involved in exocytosis ([@B30]), we checked whether mDia1 depletion or activation would affect the exocytosis of a membrane glycoprotein, temperature-sensitive vesicular stomatitis virus glycoprotein (VSVG). We did not detect, however, any differences in VSVG membrane delivery among control cells, cells expressing mDia1ΔN3, and mDia1-knockdown cells (Supplemental Figure S4).

DISCUSSION
==========

The major finding of this study is the discovery of the role of the Rho--mDia1 pathway in the modulation of Golgi architecture. This was demonstrated by experiments showing that constitutively active RhoA, as well as activation of Rho by LPA, appears to fragment the Golgi into ministacks; moreover, such fragmentation can be abolished by mDia1 knockdown. Expression of the active form of mDia1 also leads to similar Golgi fragmentation. The Rho--mDia1 pathway was also shown to be involved in the production of Rab6-positive, Golgi-derived transport vesicles.

What are the mechanisms underlying the regulation of Golgi architecture through the Rho--mDia1 pathway? In search of mDia1 involvement in the local regulation of Golgi membrane sculpting, we examined the dynamics of mDia1 localization vis-à-vis the Golgi structures. We found that upon Rho activation, an mDia1-enriched "cloud" overlaps the Golgi complex. Transient F-actin patches visualized by means of the mCherry-LifeAct were also detected in this area. More definite colocalization of mDia1 and Golgi elements was found in Rab6-positive vesicular and tubular structures.

Furthermore, we determined that the effects of Rho and mDia1 on Golgi architecture depend on actin polymerization and can be abolished by treatment of cells with latrunculin. The enhanced dispersion of the Golgi in our experiments was also inhibited by blebbistatin, indicating myosin II involvement. The mDia1-dependent actin polymerization may, in principle, modify the hypothetical actin--spectrin coat surrounding the Golgi membrane ([@B5]; [@B34]), thus affecting the membrane\'s shape and mechanical characteristics.

Our experiments with Taxol suggest that Rho-mDia1--induced Golgi fragmentation may also depend on the interactions of Golgi membranes with microtubules. Like other formins, mDia1 could, in principle, interact with microtubules either directly or via microtubule-associated proteins ([@B8]; [@B4]). Our observations of Golgi fragmentation dynamics in Taxol-treated cells are consistent with the notion that mDia1 might also modify such interactions. Thus, it appears that the Rho--mDia1 pathway controls the actin- and myosin II--mediated processes underlying the shaping and sculpting of Golgi membranes and may coordinate these processes with microtubule-based intracellular movements of the Golgi elements.

Membrane fusion and fission constitute the most basic processes underlying reorganization of complex membrane structures ([@B42]; [@B38]). Our data suggest that membrane fusion is the main mDia1-dependent process responsible for remodeling the shape of the Golgi complex. Constitutively active mDia1, as well as activation of Rho, inhibits fusion of Golgi fragments, preventing formation of Golgi ribbons in the process of recovery following nocodazole removal. During this process, knockdown of mDia1 somewhat promotes fusion of Golgi fragments.

In addition to suppressing Golgi membrane fusion, there exists some evidence that the Rho--mDia1 pathway helps to trigger fission events. In particular, the formation of Rab6- positive carriers may depend on membrane fission ([@B47]). Constitutively active RhoA was shown to augment the production of such vesicles, the majority of which displayed a spherical morphology. In contrast, mDia1 knockdown enhanced the fraction of tubular, Rab6-positive carriers in our experiments. These results, together with localization of mDia1 to the Rab6-positive membrane structures, are consistent with the possible involvement of mDia1 in Golgi membrane fission; however, the molecular and physical mechanisms underlying mDia1-dependent membrane remodeling remain elusive.

Several recent studies ([@B59]; [@B72]; [@B47]) demonstrated the involvement of other Rho-controlled, actin-associated regulatory and effector proteins in the functioning of the Golgi complex. Nonmuscle myosin II is regulated by RhoA via activation of Rho-associated kinase (ROCK) ([@B71]). More recently, it was shown that myosin II interacts directly with Rab6 and plays an important role in the formation of Rab6-positive, Golgi-derived transport carriers ([@B47]). This finding resembles the effect of the Rho--mDia1 pathway on the formation of the Rab6-positive vesicles found in our study. Our data suggest that RhoA-induced Golgi fragmentation and dispersion depend on both mDia1-driven actin polymerization and myosin II activity.

Another actin-related effector protein apparently involved in Golgi function is the actin depolymerizing protein ADF/cofilin ([@B56]; [@B59]; [@B72]). Like mDia1, ADF/cofilin is regulated by a Rho-dependent pathway; thus, active Rho, via ROCK, activates LIM kinases (LIMK1 and LIMK2), which in turn phosphorylate and inactivate cofilin ([@B6]; [@B7]). The LIMK1--cofilin pathway has been shown to participate in fission regulation ([@B59]). Finally, another Rho-binding formin, DAAM1, was recently shown to be involved in the regulation of Golgi positioning and perhaps architecture ([@B2]).

Thus, mDia1 regulates Golgi architecture and dynamics in a Rho-dependent manner, perhaps in concert with other Rho effectors controlling actin polymerization and contractility. Elucidation of the precise molecular and physical mechanisms underlying mDia1 function in these processes is a challenging subject for future study.

MATERIALS AND METHODS
=====================

Chemicals and reagents
----------------------

Nocodazole, latrunculin B, paclitaxel (Taxol), and LPA were purchased from Sigma-Aldrich (St. Louis, MO); blebbistatin from Calbiochem (Merck Eurolab, Darmstadt, Germany); and fibronectin from Biological Industries (Beit-Haemek, Israel).

HeLa JW cells ([@B50]) and HeLa JW cells stably transfected with cherry α-tubulin (kindly provided by Y. Paran and B. Geiger, Weizmann Institute of Science, Rehovot, Israel) were cultured in DMEM (Rhenium, Jerusalem, Israel) supplemented with 10% fetal calf serum (Biological Industries), [l]{.smallcaps}-glutamine, and penicillin--streptomycin solution (Sigma-Aldrich). Trypsin-EDTA (Biological Industries) was used to subculture the cells. Transfections of HeLa JW cells were performed in 36-mm dishes with jetPEI (Polyplus-transfection SA, Illkirch, France) according to the manufacturer\'s instructions.

Plasmids
--------

The mDia1-Flag, mDia1-GFP, mDia1ΔN3-GFP, and mDia1ΔN3-Flag ([@B75]; [@B33]) were kindly provided by S. Narumiya (Kyoto University Faculty of Medicine, Kyoto, Japan). For preparation of monomeric red fluorescent protein (mRFP)--mDia1ΔN3, mRFP was amplified from pRSET-B-RFP plasmid and introduced into mDia1ΔN3-GFP using *Eco*47III/*Xho*I sites instead of GFP. Mannosidase II (ManII)--GFP was a gift from V. Malhotra (Center for Genomic Regulation, Barcelona, Spain). β-GalT-YFP was purchased from Clontech (Mountain View, CA). RhoA-V14 was fused to a VSV tag, as previously described ([@B32]). Rab6A-GFP was kindly provided by S. Lev (Weizmann Institute of Science); mCherry-Rab6A′ was kindly provided by F. Perez (Institut Curie, Paris, France); and mCherry-LifeAct ([@B54]) was kindly provided by R. Wedlich-Soldner (Max Planck Institute of Biochemistry, Martinsried, Germany).

Knockdown of mDia1
------------------

Knockdown of mDia1 was performed using pSuper Dia1-shRNA (shDia1) as well as pSuper-retro-Dia1-shRNA vectors, as described previously ([@B14]). Briefly, a small interfering oligonucleotide specific for human Dia1 and corresponding to its sequence from bases 707-725 (GCATGAGATCATTCGCTGC) was synthesized, annealed and cloned in pSuper plasmids ([@B9]). The plasmids produced were then verified by DNA sequencing.

The HeLa JW siDia1 stable cell line was produced by transfection with the pSuper-retro-shDia1 plasmid. Selection was carried out in the presence of 0.4 μg/ml puromycin (Sigma-Aldrich) for 10 d. Western blot analysis of cell lysates showed an ∼90% reduction in mDia1 protein in the stably transfected cells. For mDia1 detection, mouse monoclonal antibody (mAb) against p140mDia1 (BD Biosciences, Heidelberg, Germany) was used at a 1:500 dilution in phosphate-buffered saline (PBS). Western blotting of α-tubulin (with the anti--α-tubulin antibody DM1A; Sigma-Aldrich) was used for loading control. Quantification of Western blot signals was performed using ImageJ software (National Institutes of Health, Bethesda, MD).

Immunostaining and fluorescence microscopy
------------------------------------------

After transfection, cells were plated on glass coverslips coated with fibronectin (20 μg/ml). Cells were then cultured for 24 h before treatment with drugs and fixation.

For microtubule visualization, cells were fixed as previously described ([@B81]) and stained using an indirect immunofluorescence method with mouse monoclonal anti--α-tubulin antibody (clone DM1A; Sigma-Aldrich) and Cy3- or Cy5-conjugated goat anti--mouse antibody (Jackson ImmunoResearch Laboratories, West Grove, PA). For mDia1, F-actin, and Golgi visualization, cells were fixed with 3% paraformaldehyde in PBS for 20 min at 37°C and then permeabilized with 0.25% Triton X-100 for 5 min. F-Actin was stained with coumarin--phalloidin (Sigma-Aldrich); mDia1 was stained with the mouse mAb against p140mDia1 (BD Biosciences); and Golgi was stained with mouse anti-p115 or anti-Grasp65 antibodies (a gift from S. Lev).

Fluorescence images were captured with an Olympus IX71 inverted fluorescent microscope equipped with a charge-coupled device camera (CoolSNAP HQ; Photometrics, Tucson, AZ) and controlled by a DeltaVision system (Applied Precision, Issaquah, WA). A dichroic mirror and excitation and emission filter wheels (Chroma Technology, Rockingham, VT) were adjusted for detection of fluorescein isothiocyanate (FITC), 4′,6-diamidino-2-phenylindole, rhodamine, and Cy-5.

Observations of the colocalization of GFP-mDia1 and Cherry-Rab6A′ were carried out using a PerkinElmer spinning-disk confocal microscope based on an inverted Olympus microscope IX81, equipped with a PL FL 100× 1.4--numerical aperture (NA) objective lens, Hamamatsu C9100-13 EMCCD camera for image acquisition, and Volocity software to control the setup (PerkinElmer, Waltham, MA). Acquisition parameters were 100-ms exposure for the 488 channel and 100 ms for the 561 channel. Lasers ware set to 24% in each case. Images were converted into TIFF files by ImageJ software and arranged into figures using Adobe Photoshop (San Jose, CA).

Transmission electron microscopy was performed as described ([@B40]).

Videomicroscopy
---------------

Cells transfected with the plasmids listed were replated on fibronectin-coated, glass-bottomed dishes (MatTek Corporation, Ashland, MA) 6 h after transfection and placed on the microscope stage 24-36 h later. Images were recorded on an Olympus IX71 inverted fluorescence microscope equipped with a temperature and CO~2~ control unit (Life Imaging Services, Reinach, Switzerland). Objectives used were Olympus plan ApoN 60× 1.42 NA or Olympus 100× 1.3 NA UplanFI. Images were filtered using the Unsharp Mask plug-in of Image J and converted to movies.

Image analysis
--------------

Vesicle density was measured using the ImageJ Analyze Particles plug-in applied to the polygon drawn around the cell. Before analysis, images were convolved and thresholded for better vesicle segmentation.

Golgi morphology was quantified using an index of circularity or compactness defined as 4π × Area/Σ Perimeter^2^ ([@B3]), where Area represents the total Golgi projected area and Σ Perimeter is the sum of the perimeters of all Golgi fragments. All of the parameters were measured per cell. The compactness index approaches the maximal value of 1 for the most compact shape, namely, a circle. At least 30 cells were taken for each measurement.
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ADF

:   actin depolymerizing factor

ER

:   endoplasmic reticulum

GalT-YFP

:   N-terminal fragment of β-galactosiltransferase fused to yellow fluorescent protein (a marker for *trans*-Golgi)

GFP

:   green fluorescent protein

Lifeact

:   a 17-amino-acid peptide, which stained filamentous actin (F-actin)

LIMK

:   LIM domain kinase

LPA

:   lysophosphatidic acid

ManII-GFP

:   a Golgi enzyme mannosidase II fused to green fluorescent protein (a *cis*/medial-Golgi marker)

mCherry-Lifeact

:   mCherry fluorescent protein fused to Lifeact, a probe for F-actin

mDia1ΔN3

:   a truncated constitutively active derivative of mDia1

ROCK

:   Rho-associated protein kinase

VSVG

:   vesicular stomatitis virus glycoprotein
